Interferon reduced the production of virus neuraminidase during single-cycle growth of A2/HK/I/68 or recombinant X7(Fa) influenza viruses in chicken embryo cell cultures. Neuraminidase activity, measurable within 6 h after infection, was reduced as much as 7o to 8o ~o below control levels in interferon-treated cultures. X7(F1) neuraminidase yield was at least as sensitive a measure of interferon inhibition as vesicular stomatitis virus in the standard plaque-reduction assay. Interferon titre, expressed as the 3o ~ neuraminidase reduction dose or NRD30, is derived from semi-logarithmic sigmoidal dose-response curves. The advantages that recommend the neuraminidase reduction bioassay for interferon assay include the precision of the enzyme assay ( _+ I "o ~), the precision of measurement of replicate samples of interferon ( + 9 ~), the reproducibility of interferon titres obtained sequentially ( + 20 ~o), as well as the rapidity and economy of the method.
INTRODUCTION
Neuraminidase (N-acetylneuraminate-glycohydrolase, E.C. 3.2.I.~8) is one of the important surface components of viruses of the myxovirus and paramyxovirus groups. This virus-specific enzyme can be readily detected in cellular plasma membranes within hours after infection (Kendal & Apostolov, 197o ) . Uninfected chicken embryo cell cultures, highly susceptible to infection with certain myxoviruses, have no detectable neuraminidase activity (Lipkind & Tsvetkova, I967) . The assay of the production of this influenza virus enzyme in cultured chicken embryo cells provides a highly precise, rapid, simple, and economical means to measure interferon action. To establish the validity of this bioassay of interferon, certain characteristics of the virus enzyme and several biological parameters were studied.
METHODS

Cell cultures. Primary chicken embryo cell cultures (CEC) were prepared from Io-day-old
White Leghorn embryos. The cells were dispersed during a 3 h incubation at room temperature with o-2 ~o trypsin in complete Hanks' balanced salt solution (HBSS) without antibiotics, filtered through a funnel with four layers of gauze, and washed twice with complete HBSS containing 5 ~ calf serum. Two ml of the cell suspension, containing 2. 5 to 3"5 x io 6 cells/ml of growth medium, were dispensed on to a I2"5 cm 2 surface in soft-glass bottles and incubated at 36 °C. Growth medium consisted of 5 ~ heat-inactivated calf serum, oq yeastolate (Difco), penicillin (IOO units/ml), streptomycin (IOO #g/ml), and mycostatin (5o units/ml) in HBSS. (Grossberg, I964) as well as by measurement of haemagglutinin and neuraminidase. Vesicular stomatitis virus (VSV) was prepared and titrated as previously described (Morahan & Grossberg, I97oa) .
Interferon preparation. Interferon was prepared from the allantoic fluid of A0/WS/33 influenza virus-inoculated chicken embryos and partially purified as previously described (Morahan & Grossberg, I97ob) .
Neuraminidase assay. Neuraminidase was assayed by the thiobarbituric acid (TBA) method of Warren (I959) as modified by Webster & Pereira (I968) . Fetuin (Grand Island Biological Company, Grand Island, N.Y.) , 6 mg/ml, was used as enzyme substrate without further purification, and mixtures of twice-frozen-and-thawed cultured cells and supernatant fluids were the source of virus enzyme. The double cycle of freezing and thawing was necessary to release cytoplasmic and membrane-bound neuraminidase. The quantity of enzyme used was o.I ml either of the culture mixture or of a dilution that would give an E550 of o'5 to o'7 in I h. One unit of enzyme activity is defined as the amount of enzyme necessary to release one n-mol of N-acetylneuraminic acid (NANA) from fetuin substrate per h, at 37 °C. The TBA derivative of the product of neuraminidase activity had an absorption spectrum identical to that of the TBA derivative of 99 ~o pure NANA (General Biochemicals, Chagrin Falls, Ohio).
Haemagglutination. The fluids from twice-frozen-and-thawed cultures were titrated at Interferon inhibition of yields of neuraminidase, haemagglutinin and virus. Growth medium was decanted from confluent CEC, and cultures were overlaid with I-o ml of either GLM (I ~o gelatin, 0"5 ~ lactalbumin hydrolysate, penicillin, streptomycin, and mycostatin in Scherer's maintenance medium in which parenamine was replaced by its constituent amino acids), (Microbiological Associates, Inc., Bethesda, Maryland) or interferon diluted in GLM. After I6 to I8 h the supernatant fluid was decanted, the CEC washed twice with ~.o ml of GLM and then infected with o.I ml of virus diluted in GLB (o'5 ~ gelatin and o'25 ~ lactalbumin hydrolysate in complete HBSS) to give an input multiplicity of between t and Io p.f.u./cell. Virus was allowed to attach to gently oscillating cultures for I h at 36 °C. Infected cells were then washed three times with GLM and overlaid with o.I ml of GLM for incubation at 36 °C in closed bottles. The cell cultures were harvested at intervals and frozen at -7o °C. After thawing in a 37 °C water bath, the cultures were subjected to a second freeze-thaw cycle before determination of neuraminidase activity, H.A., and p.f.u. (Grossberg, I964) . Interferon titres were expressed as the 30 ~o neuraminidase reduction dose (NRDa0) (see Results).
Plaque-reduction assay for interferon. The assay determined the dilution of interferon which reduced the number of plaques formed by VSV on Io-day chicken embryo cell cultures (Wagner, I96o ) . Titres are expressed either as median plaque-depressing dose (PDDs0) or as the 27 ~ plaque development or survival dose (PSD27) Oordan, 2972). 
RESULTS
Kinetics of myxovirus neuraminidase
The assay of neuraminidase was validated in the following experiments with the A2/HK/ 1/68 enzyme and commercial fetuin as substrate. Sufficient enzyme was used to release 4 ° n-mol of NANA in 5o min as measured with the standard assay. The rate of formation of free NANA from fetuin exhibited saturation kinetics with a Michaelis constant of 2.6 mg/ ml ( Fig. [ (a) and I (b) ). The rate of formation of NANA with non-limiting substrate was linear up to 6o min at the concentrations of enzymes tested (Fig. ~ (c) ) and the rate of formation of NANA was linearly dependent on the enzyme concentration ( Fig. ~ (d) ). Similar kinetics were obtained for the X7(Fa) enzyme with a Michaelis constant of 5"~ mg/ml.
Kinetics of virus growth and inhibition by interferon
A~/HK/I/68 and X7(F1) were selected as most suitable from a number of myxoviruses tested for neuraminidase production and sensitivity to interferon. Duplicate cultures treated for ~8 h with either maintenance medium or 2o0 PDDs0 of interferon were assayed for neuraminidase and I-I.A. at intervals after A2/HK/I/68 infection. An appreciable increase of neuraminidase in control cultures was detected 6 h after infection (Fig. 2(a) ). Interferon treatment reduced neuraminidase activity by 75 % at 6 h and by 60 % at 24 h. The results of a similar experiment with X7(F0 shown in Fig. 2 (b) correlate the depression by interferon of X7 (F1) tures treated with 200 PDD~0 of interferon was inhibited 72 ~ at 6 h and 80 % at 24 h after challenge. Whereas the ratio of total (free and cell-associated) neuraminidase to H A. production in CEC for A2/HK/I/68 virus was 2, the ratio for X7(F1) was 1o; these ratios did not significantly change as a result of inhibition by interferon.
Development of antivirus resistance as a function of time after addition of interferon
Pre-treatment with Ioo PDDso interferon for a minimum of about 6 h was necessary for the development of maximum resistance to challenge with either virus. However, when Ioo PDDs0 units of interferon were added simultaneously with the Az/HK/ff68 virus and neither subsequently removed, the same degree of reduction of neuraminidase yield (59 %) was observed as in cultures pretreated for 18 h.
Dose-response relationships: interferon concentrations and neuraminidase production
Neuraminidase activity was measured 6 h after infection in sextuplicate cultures treated with four dilutions of interferon before challenge with A2/HK/U68 (input multiplicity of I.o p.f.u./cell). The results in Table I illustrate the high precision of graded antivirus response measured in relation to interferon concentration. The standard deviation of the samples ranged from 3 ~ of the mean value at one dilution of interferon to ~ 8 ~ at another. Higher input multiplicity increased neuraminidase production but did not alter the graded response to interferon. The presence of z-deoxyribose is believed to account for the small background E550 in uninfected controls and in infected cell extracts without fetuin substrate. The extinction was essentially the same for a standard preparation of NANA as for NANA incubated in the presence of infected cell extract for ~ h. These observations suggest that NANA aldolase or other interfering enzymes were not present in the cell extracts.
The plot of data (Fig. 3) as the percentage of control neuraminidase activity against the logarithm of the reciprocal of the interferon dilution gives a sigmoidal dose-response curve with a rectilinear region extending from 40 to 85 ~o of control activity, corresponding to a reduction of I5 to 50 ~. The 3o ~ neuraminidase reduction end-point (NRD~0) was selected because it fell near the midpoint of the linear portion of the majority of doseresponse curves. The sigmoidal dose-response curves obtained are typical of other plots of interferon titrations (Gifford & Koch, 1969; Hallum, Thacore & Youngner, 197o; Jordan, 1972) .
Interferon titres obtained in six sequential titrations were highly reproducible in cultures harvested 6 or 24 h after infection. The rectilinear portions of all dose-response curves were parallel. One preparation assayed with X7(F1) as challenge and tested 24 h after infection had a mean titre of IOOI with a standard deviation of I9. 5 %. Such reproducibility compares well to a highly reproducible method based on the incorporation of radioactively labelled uridine into virus RNA (Allen & Giron, I97O; Koblet, Kohler & Wyler, 1972) .
Another interferon preparation measured at 6 h had a mean titre of I75 with a standard devation of 25 % of the mean when A2/HK/I/68 was used as a challenge; titres measured at 24 h were consistently lower (mean NRDa0 of 49) with a standard deviation of 25 %. Thus, the apparent titre of interferon, reflecting sensitivity of a given virus to interferon, diminished during a single cycle of virus growth of A2/HK/I/68 but not of X7(F1) virus. Whether an inhibitor of interferon (Ghendon, 1965; Grossberg & Morahan, I971) is induced during the replication of A2/HK/I/68 virus remains undetermined.
Comparative sensitivity of neuraminidase yield-reduction test
When the potency of an interferon preparation (81771) was measured simultaneously by the X7(F1) neuraminidase-reduction and VSV plaque-reduction methods, the NRD30 titres were at least equivalent to the 5o % VSV plaque-reduction titre. If the plaque-reduction titre is instead calculated as a 73 % reduction, or PSD27, as recently recommended (Jordan, i972) , the X7(F1) NRD~o titre (I3OO) is threefold higher than the VSV plaque-reduction titre (45o). The NRDa0 titre of the Medical Research Council interferon standard (67/18) was IOO, slightly higher than the 79 units assigned to it. The bioassay is thus suitably sensitive.
DISCUSSION
Myxoviruses are generally considered to be sensitive to interferon action. Reduction in the yield of influenza virus haemagglutinin was used for the bioassay of interferon in the earliest studies of Isaacs & Lindenmann (1957) . In the studies reported here neuraminidase characteristically paralleled haemagglutinin production, and interferon reduced the yield of both structural components as well as infectious virus. The high ratio of total neuraminidase to haemagglutinin observed after infection of chicken embryo cells with X7(F1) virus and the sensitivity of this recombinant to interferon action recommend its use in the neuraminidase bioassay.
This single-cycle, yield-reduction method may overcome the several disadvantages of current interferon bioassays (Grossberg, 1972 ) in precision, reproducibility, and the relatively brief period of virus growth needed prior to assay of the enzyme. The method is also economical, requiring inexpensive glycoprotein substrates and relatively simple equipment, features which have made it possible to automate the neuraminidase assay (Kendal & Madeley, I969) , providing a means to measure numerous interferon preparations.
The extension of this technique to other cultured cells requires the demonstration of low background levels of cellular neuraminidase, since such enzymes are known to occur normally in certain tissues (Lipkind & Tsvetkova, 1967) . We have recently been able to utilize this interferon bioassay in a variety of mammalian cell cultures, including human cells.
